Effective Internal and External Partnerships in Oncology Trials

Ridwaan Jhetam, Global Clinical Operations Head Oncology Senior Director, Johnson and Johnson discusses optimal outsourcing strategies to safeguard the trial design and aims of the study, solutions for cutting costs without compromising drug development activities and identifying expertise and finding the right trial external partners to fit the needs of the trial. Jhetam also shares his insights on making the matrix work for cross-functional teams involved in drug development and project management and monitoring to minimise delays and cost overruns.


Presented at Pharma IQ's Optimising Clinical Development in Oncology in April 2010.

To continue reading this story

Learn More   Existing Users